about
Structure-Based Drug Discovery for Prion Disease Using a Novel Binding SimulationA Novel Potent and Highly Specific Inhibitor against Influenza Viral N1-N9 Neuraminidases: Insight into Neuraminidase-Inhibitor Interactions.Identification of small molecule inhibitors for influenza a virus using in silico and in vitro approaches.Ca(2+) monitoring in Plasmodium falciparum using the yellow cameleon-Nano biosensor.Fragment Molecular Orbital method-based Molecular Dynamics (FMO-MD) as a simulator for chemical reactions in explicit solvation.Computational study of the competitive binding of valproic acid glucuronide and carbapenem antibiotics to acylpeptide hydrolase.Molecular cloning and biochemical characterization of isoprene synthases from the tropical trees Ficus virgata, Ficus septica, and Casuarina equisetifolia.Prediction of peptide binding to a major histocompatibility complex class I molecule based on docking simulation.Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction.Crystal structure of the N-myristoylated lipopeptide-bound MHC class I complex.Interaction Analysis of the Native Structure of Prion Protein with Quantum Chemical Calculations.Protein-specific force field derived from the fragment molecular orbital method can improve protein-ligand binding interactions.Theoretical study of the prion protein based on the fragment molecular orbital method.Fragment molecular orbital calculations on red fluorescent proteins (DsRed and mFruits).Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke.Origin of Stereoselectivity and Substrate/Ligand Recognition in an FAD-Dependent R-Selective Amine Oxidase.Identification of Alprenolol Hydrochloride as an Anti-prion Compound Using Surface Plasmon Resonance Imaging.Spin polarized metastable He*(2(3)S, 1s2s) stimulated desorption of H(+) ions.Fragment Molecular Orbital Study of the Interaction between Sarco/Endoplasmic Reticulum Ca-ATPase and its Inhibitor Thapsigargin toward Anti-Malarial DevelopmentRI-MP3 calculations of biomolecules based on the fragment molecular orbital methodPrediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistanceHow does an S(N)2 reaction take place in solution? Full ab initio MD simulations for the hydrolysis of the methyl diazonium ionTheoretical study of the photoinduced transfer among the ground state and two metastable states in [Fe(CN)5NO]2-RI-MP2 Gradient Calculation of Large Molecules Using the Fragment Molecular Orbital MethodDevelopment of an Analysis Toolkit, AnalysisFMO, to Visualize Interaction Energies Generated by Fragment Molecular Orbital CalculationsA Quinolinone Compound Inhibiting the Oligomerization of Nucleoprotein of Influenza A Virus Prevents the Selection of Escape MutantsRoles of YIGL sequence of Ebola virus VP40 on genome replication and particle productionCharacterization of Entamoeba histolytica adenosine 5'-phosphosulfate (APS) kinase; validation as a target and provision of leads for the development of new drugs against amoebiasisA designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaques
P50
Q28831416-A6383DBE-1A0F-4DC9-A3C4-6E93B00E949AQ30387117-1E324A48-3EFF-47C2-83CF-975169C10B09Q36300881-A4B5AA87-CC90-454F-8784-8B08C468DB5CQ36719348-F7190DE8-B65E-493E-82F9-6E6D9D2BEBB0Q38500947-08BE70EE-9BB8-4268-BE2E-B39722620F0AQ38666670-AA2978D2-F309-4DDA-92F4-6AF56356A0B3Q39320841-AFF63C2A-A9C1-4E99-ACE2-DA95058D913AQ39394471-B39CA3BC-5350-482A-BC91-D84071215625Q39580310-C3CBAE6A-32F1-4C56-9859-0A6F6F6CA15EQ40116672-E5AB738E-0D4F-4CE5-974D-78692FE4A030Q44459683-CF52D4DA-3CEB-4D20-817C-25E68B699D1CQ45716121-46D24F22-ED90-4B2B-A151-11FFDCD9D561Q46029199-1775C80E-B390-4A24-8456-30EA245003D1Q46172696-5CF78B45-6BB2-4DCC-A989-90E221CF6A66Q47797257-602BE19D-DE6D-4941-8A08-0AC4878464E5Q51485614-0CC361F2-71AC-48AD-890B-4A83D795F5EFQ52716065-B93310CB-BA2F-46FC-98C1-E47D45A5CBFFQ54423476-7E14A020-7964-4C6D-8857-77FE9DCC9448Q56341638-AB933C2C-5420-4077-BD15-4B046A701137Q57112579-330DDE33-22DB-4007-B780-C9D2FFA9FBF2Q64286743-6A514E22-9C77-4D0C-B7A9-375413F5F20FQ80636729-E62C9377-D48E-4F5C-A599-8D5BFF736E95Q81468952-EF95671E-58C1-4C28-B0FC-EDBB08AB02DFQ85926398-C79898A5-FFAC-48C1-A1F6-645E32229B85Q90281448-BDFB1B9C-3953-4CA8-AF32-9FFB8E88F59AQ90598908-1D4D9ABA-3E70-4897-8637-8A777F26B1C0Q92654726-47537038-47C8-48C4-BCDA-4DD2FBA50A5CQ92697524-944DA56B-866D-44AB-B878-EE2EF9C3C382Q92861262-1C9F6BFE-48D9-478F-8BF9-52CFE8C5D8F5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Takeshi Ishikawa
@ast
Takeshi Ishikawa
@en
Takeshi Ishikawa
@es
Takeshi Ishikawa
@nl
type
label
Takeshi Ishikawa
@ast
Takeshi Ishikawa
@en
Takeshi Ishikawa
@es
Takeshi Ishikawa
@nl
prefLabel
Takeshi Ishikawa
@ast
Takeshi Ishikawa
@en
Takeshi Ishikawa
@es
Takeshi Ishikawa
@nl
P106
P1153
55465137800
P2456
P31
P496
0000-0002-3187-1381